Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report
May 11, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report...
Immuno-Oncology (IO) Market is Expected to Reach the Valuation of USD 156.05 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis
April 27, 2023 03:43 ET
|
Data Bridge Market Research
MELBOURNE, April 27, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has unveiled a new report called "Immuno-Oncology (IO) Market" which provides an in-depth exploration of growth strategies,...
Global Immuno Oncology Market Size To Grow USD 154.57 Billion By 2030 | CAGR of 22.9%
March 27, 2023 12:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , March 27, 2023 (GLOBE NEWSWIRE) -- The Global Immuno Oncology Market Size to Grow from USD 26.9 Billion in 2021 to USD 154.57 Billion by 2030, at a Compound Annual Growth...
Global Cancer Monoclonal Antibodies Market Report 2023: Players Include Amgen, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche and Genmab
March 22, 2023 12:04 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
$120+ Billion Worldwide Immuno-Oncology Drugs Industry to 2032: Rising Number of Cancer Cases Drives the Market
March 13, 2023 12:33 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
2023 Annual Next-Gen Immuno-Oncology Congress: Latest Updates in ADC's, mAb, BsAbs, Immune Checkpoint Inhibitors, and Cellular Therapy (Boston, MA, United States - June 22-23, 2023)
March 09, 2023 09:18 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "6th Annual Next-Gen Immuno-Oncology Conference" conference has been added to ResearchAndMarkets.com's offering. The 6th Annual Next Gen...
Market Forecasts for Immuno-Oncology Diagnostics 2023: Outcome Potential and Companion Diagnostics Driving Growth
January 16, 2023 07:58 ET
|
Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2023 to 2027" report has...
Global Immuno-Oncology Diagnostics Market Research Report 2023: Gain an Understanding of Growth Expectations and the Ultimate Potential Market Size
January 13, 2023 04:53 ET
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.com's...
Global Head And Neck Cancer Therapeutics Market Report 2022: Featuring Eli Lilly, Merck, Sanofi, Takeda Pharmaceutical & More
January 09, 2023 07:48 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and...
Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More
November 29, 2022 08:08 ET
|
Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market, by Drug Class, By Cancer Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...